DekaBank Deutsche Girozentrale
LEGN icon

DekaBank Deutsche Girozentrale’s Legend Biotech LEGN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Hold
9,862
– – ﹤0.01% 980
2026
Q1 		$181K Hold
9,862
– – ﹤0.01% 981
2025
Q4 		$3.96M Hold
9,862
– – 0.01% 629
2025
Q3 		$322K Hold
9,862
– – ﹤0.01% 1062
2025
Q2 		$341K Buy
9,862
+82
+0.8% +$2.66K ﹤0.01% 1043
2025
Q1 		$336K Sell
9,780
-82
-0.8% -$2.94K ﹤0.01% 1036
2024
Q4 		$323K Hold
9,862
– – ﹤0.01% 1074
2024
Q3 		$480K Sell
9,862
-1,710
-15% -$91.1K ﹤0.01% 1022
2024
Q2 		$514K Buy
11,572
+1,792
+18% +$82.7K ﹤0.01% 999
2024
Q1 		$555K Sell
9,780
-92
-0.9% -$5.55K ﹤0.01% 986
2023
Q4 		$589K Sell
9,872
-1,374
-12% -$87.1K ﹤0.01% 1004
2023
Q3 		$756K Sell
11,246
-843
-7% -$58.5K ﹤0.01% 932
2023
Q2 		$851K Sell
12,089
-112
-0.9% -$7.32K ﹤0.01% 915
2023
Q1 		$581K Buy
12,201
+1,467
+14% +$71.8K ﹤0.01% 988
2022
Q4 		$532K Sell
10,734
-3,098
-22% -$150K ﹤0.01% 1018
2022
Q3 		$550K Sell
13,832
-13
-0.1% -$610 ﹤0.01% 1024
2022
Q2 		$745K Buy
13,845
+1,459
+12% +$61.6K ﹤0.01% 942
2022
Q1 		$2.02M Buy
12,386
+3,551
+40% +$140K ﹤0.01% 747
2021
Q4 		$417K Buy
8,835
+2,835
+47% +$144K ﹤0.01% 1140
2021
Q3 		$284K Hold
6,000
– – ﹤0.01% 1142
2021
Q2 		$243K Hold
6,000
– – ﹤0.01% 1184
2021
Q1 		$172K Hold
6,000
– – ﹤0.01% 1208
2020
Q4 		$173K Buy
+6,000
New +$173K ﹤0.01% 1200

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LEGN Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Legend Biotech (LEGN) position steady in Q2 2026 at 9,862 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

DekaBank Deutsche Girozentrale first reported a position in LEGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.96M in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 9,862 shares of Legend Biotech worth $178K as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #980 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Legend Biotech in Q4 2020 and has held it in 23 quarters since.
  • DekaBank Deutsche Girozentrale's Legend Biotech position peaked at $3.96M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.